Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, we spoke with Deena Kuruvilla, MD, director, Westport Headache Institute, who spoke to the current state of affairs in the clinical care of migraine. She also shared her insight into the issues that specialists need to overcome, such as access to therapy, the real-world use of novel treatments for headache disorders, and the advances that are currently in the research and development stage.
Episode Breakdown:
1:25 – Trends in the clinical care of migraine over the last year5:00 –The effect of the COVID-19 pandemic on patients with migraine7:05 – Ongoing barriers of access to migraine treatments9:20 – Neurology News Minute13:25 –Addressing the need for more migraine specialists15:55 –Real-world use of available migraine therapies and devices17:20 – Recent introductions to the physician's migraine toolkit20:40 – Lingering therapeutic needs in migraine and the role of advocacy in improving care
The stories featured in this week's Neurology News Minute are further detailed here:
FDA Approves Vivistim VNS System for Ischemic Stroke Motor DeficitsFDA Approves Brivaracetam for Partial-Onset Seizures in Pediatric EpilepsyAcute Migraine Treatment INP104 Approved
Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.